| Literature DB >> 24436882 |
Karen K Anderson1, Paul M Arnold1.
Abstract
Study Design Review. Objective Postoperative oropharyngeal dysphagia is one of the most common complications following anterior cervical spine surgery (ACSS). We review and summarize recent literature in order to provide a general overview of clinical signs and symptoms, assessment, incidence and natural history, pathophysiology, risk factors, treatment, prevention, and topics for future research. Methods A search of English literature regarding dysphagia following anterior cervical spine surgery was conducted using PubMed and Google Scholar. The search was focused on articles published since the last review on this topic was published in 2005. Results Patients who develop dysphagia after ACSS show significant alterations in swallowing biomechanics. Patient history, physical examination, X-ray, direct or indirect laryngoscopy, and videoradiographic swallow evaluation are considered the primary modalities for evaluating oropharyngeal dysphagia. There is no universally accepted objective instrument for assessing dysphagia after ACSS, but the most widely used instrument is the Bazaz Dysphagia Score. Because dysphagia is a subjective sensation, patient-reported instruments appear to be more clinically relevant and more effective in identifying dysfunction. The causes of oropharyngeal dysphagia after ACSS are multifactorial, involving neuronal, muscular, and mucosal structures. The condition is usually transient, most often beginning in the immediate postoperative period but sometimes beginning more than 1 month after surgery. The incidence of dysphagia within one week after ACSS varies from 1 to 79% in the literature. This wide variance can be attributed to variations in surgical techniques, extent of surgery, and size of the implant used, as well as variations in definitions and measurements of dysphagia, time intervals of postoperative evaluations, and relatively small sample sizes used in published studies. The factors most commonly associated with an increased risk of oropharyngeal dysphagia after ACSS are: more levels operated, female gender, increased operative time, and older age (usually >60 years). Dysphagic patients can learn compensatory strategies for the safe and effective passage of bolus material. Certain intraoperative and postoperative techniques may decrease the incidence and/or severity of oropharyngeal dysphagia after ACSS. Conclusions Large, prospective, randomized studies are required to confirm the incidence, prevalence, etiology, mechanisms, long-term natural history, and risk factors for the development of dysphagia after ACSS, as well as to identify prevention measures. Also needed is a universal outcome measurement that is specific, reliable and valid, would include global, functional, psychosocial, and physical domains, and would facilitate comparisons among studies. Results of these studies can lead to improvements in surgical techniques and/or perioperative management, and may reduce the incidence of dysphagia after ACSS.Entities:
Keywords: anterior approach; cervical spine surgery; complication; dysphagia; oropharyngeal
Year: 2013 PMID: 24436882 PMCID: PMC3854602 DOI: 10.1055/s-0033-1354253
Source DB: PubMed Journal: Global Spine J ISSN: 2192-5682
Fig. 1Soft tissue edema following anterior cervical discectomy and fusion (ACDF).
Fig. 2Swimmer's view shows soft tissue swelling after C5–7 anterior cervical discectomy and fusion (ACDF).
Fig. 3Swallow study, 6 days postoperatively. Note contrast extravasation along the posterior aspect of the esophagus at C6 with a small collection in the prevertebral space, consistent with esophageal leak. Contrast was also seen injuring the trachea extending into the bilateral main stem bronchi area, consistent with aspiration due to swallow dysfunction.
Bazaz Dysphagia Score
| Episodes of swallowing difficulty (by patient report) | ||
|---|---|---|
| Severity of dysphagia | Liquid | Solid |
| None | None | None |
| Mild | None | Rare |
| Moderate | None or rare | Occasional (only with specific foods like bread or meat) |
| Severe | Present | Frequent (and with a majority of solids) |
Adapted from Bazaz et al, 2002.35
Various patient-reported instruments used in recent literature
| Name of instrument | Notes |
|---|---|
| MDADI | Both validated, although patients with ACSS comprise a subgroup with less severe symptoms than are usually evaluated with these two instruments |
| DSQ and the modified DSQ | An “expert opinion” validation that has good correlation with the MDADI |
| DDI | An interview for subjective complaints |
| VAS | For neck, arm, and iliac graft site pain |
| Telephone interviews | Using Bazaz questions as template |
| Patient reports of difficulty swallowing solids and/or liquids | Including frequency |
| Use of pain drawings, pain medication use, and patient's overall opinion of treatment success |
Abbreviations: ACSS, anterior cervical spine surgery; DDI, Dysphagia Disability Index; DNRS, Dysphagia Numeric Rating Scale; DSQ, Dysphagia Short Questionnaire; MDADI, MD Anderson Dysphagia Inventory; SWAL-QOL, Swallowing-Quality of Life Survey; VAS, Visual Analog Scale.
Causes of oropharyngeal dysphagia according to categories, with corresponding representative conditions
| Categories of causes | Representative conditions |
|---|---|
| Collagen diseases | Scleroderma, dermatomyositis |
| Conditions that give rise to fixed mechanical obstruction | Previous surgical treatment, tumor, cervical rings or webs, radiation/radiotherapy (pharyngeal phase) |
| Congenital neurologic/structural disorders/malformations | Dysautonomia, cleft palate, cerebral palsy, muscular dystrophy |
| Iatrogenic | Medications (chemotherapy, neuroleptics, etc.); pill injury (intentional; oral preparatory phase) |
| Infectious | Botulism, diphtheria, Lyme disease, mucositis (herpetic lesions, cytomegalovirus, Candida, aphthous ulcers); syphilis (oral preparatory phase) |
| Intrinsic functional disturbances | Cricopharyngeal achalasia, Zenker diverticulum (pharyngeal phase) |
| Medical | Advanced chronic obstructive pulmonary disease, deconditioning, intubation (prolonged endotracheal), rheumatoid arthritis, some viral infections |
| Metabolic | Amyloidosis, Cushing syndrome, thyrotoxicosis, Wilson disease |
| Myopathic | Connective tissue disease (overlap syndrome), myotonic dystrophy, paraneoplastic syndromes, polymyositis, sarcoidosis |
| Neurologic | Dementia, Guillain-Barré syndrome, Huntington disease, metabolic encephalopathies, polio, postpolio syndrome, traumatic brain injury, seizure disorders, tardive dyskinesia, brainstem tumor, cerebral vascular accident |
| Neuromyogenic | Myopathies (inflammatory, metabolic), parkinsonism, head trauma, stroke (oral preparatory phase and pharyngeal phase) |
| Progressive neurologic disorders | Dystonia, progressive supranuclear palsy, oculopharyngeal dystrophy, myasthenia gravis, amyotrophic lateral sclerosis, multiple sclerosis, Parkinson's disease (oral preparatory phase and pharyngeal phase) |
| Neurosurgical procedures | Aneurysm clippings, anterior cervical spine surgery; resection of tumor |
| Structural | Extrinsic compression, cervical osteophytes, scar tissue (oral/pharyngeal), stenosis (postsurgical/radiation/idiopathic), cricopharyngeal bar, skeletal abnormalities (pharyngeal phase) |
Causes of oropharyngeal dysphagia according to operative approach and operative technique
| Approach/technique | Possible resulting condition |
|---|---|
| Operative approach (anterior) | |
| Dissection or retraction | Damage of the aerodigestive pathway |
| Dissection or retraction of the longus colli muscle | Muscle and subperiosteal bleeding; prevertebral soft tissue swelling |
| Retraction | Denervation of the pharyngeal plexus |
| Excessive or prolonged retraction | Dysphagia |
| Significant tension during lateralization of the larynx (RLN most at risk with surgery involving C3–C4 and C5–T1) | RLN injury, which can cause vocal fold paresis or paralysis |
| RLN stretch injury and/or RLN compression injury from ET cuff compression | RLN palsy, which can cause vocal fold paresis or paralysis |
| Use of rh-BMP-2 | Early local inflammatory response to rh-BMP-2 (dose-related) |
| Concurrent intraoperative traction on both the RLN and pharyngeal plexus | RLN injury |
| Other aspects of operative approach | |
| Direct esophageal injury | Impaired opening of the upper esophageal sphincter |
| Hemostatic or coagulopathy | Hematoma formation |
| Operative technique | |
| Use of instrumentation | Any mechanical irritation or impingement against the esophagus |
| Thickness or anterior profile of anterior cervical plates and instrumentation | Irritation and inflammation |
| Plate on the esophagus | Mass effect |
| Use of graft | Graft (implant) protrusion, |
| Improper halo or collar positioning | Cervical hyperextension |
Abbreviations: ET, endotracheal; rhBMP-2, recombinant human bone morphogenetic protein-2; RLN, recurrent laryngeal nerve; SLN, superior laryngeal nerve.
Summary of incidence and prevalence rates
| Author, year | No. of patients | Assessment tool | Immediate postoperative (<2 wk) | 2 wk: incidence | 1 mo–6 wk | 8 wk–3 mo | 6 mo | 12 mo | 24 mo |
|---|---|---|---|---|---|---|---|---|---|
| Lee et al, 2005 | 156 | Bazaz Dysphagia Score by telephone | x | x | Incidence: 48.9%; prevalence: x | Incidence: x; prevalence: 37.0% | Incidence: x; prevalence: 20.9% | Incidence: x; prevalence: 15.4% | Incidence: x; prevalence: 11.4% |
| Riley et al, 2005 | 454 | CSOQ self-report of swallowing impairment | x | x | x | Incidence: 28.2%; prevalence: x | Incidence: 6.8%; prevalence: 21.5% | x | Incidence: 7%; prevalence: 21.3% |
| Yue et al, 2005 | 74 | Bazaz Dysphagia Score | x | x | x | x | Incidence: x; prevalence at undefined “early postoperative period”: 45.9% | x | Incidence: x; prevalence at 5+ y: 35.2% |
| Chin et al, 2007 | 64 | Telephone assessment of subjective swallowing difficulties | 34% | x | x | Incidence: x; prevalence at >4 wk: 17% | x | x | x |
| Lee et al, 2007 | 310 | Bazaz Dysphagia Score | x | x | Incidence: 54%; prevalence: x | Incidence: x; prevalence: 33.6% | Incidence: x; prevalence: 18.6% | Incidence: x; prevalence: 15.2% | Incidence: x; prevalence: 13.6% |
| Papavero et al, 2007 | 92 | Modified dysphagia questionnaire | At < 5 d postoperatively: 49.3% | x | x | x | x | x | x |
| Tervonen et al, 2007 | 114 | VAS for all; transoral endoscopic evaluation and videofluorography for some | 69% | x | x | Incidence: x; prevalence at 3–9 mo: 27% | Incidence: x; prevalence at 3–9 mo: 27% | x | x |
| Vaidya et al, 2007 | 18 | Bazaz Dysphagia Score | 56% | 39.0% | Incidence: 22%; prevalence: x | x | x | x | Incidence: x; prevalence: 22.0% |
| McAfee et al, 2010 | 251 | Bazaz Dysphagia Score; hoarseness VAS | x | x | Incidence: 57.8%; prevalence: x | Incidence: x; prevalence: 38.5% | Incidence: x; prevalence: 27.2% | Incidence: x; prevalence: 28.9% | Incidence: x; prevalence: 27.6% |
| Riley et al, 2010 (systematic review) | N/A | N/A | 33.1% (range 1–79%) | x | Incidence: x; prevalence: 53.2% (range 50–56%) | Incidence: x; prevalence: 31.6% (range 28–37%) | Incidence: x; prevalence: 19.8% (range 8–22%) | Incidence: x; prevalence: 16.8% (range 13–21%) | Incidence: x; prevalence: 12.9% (range 11–14%) |
| Pattavilakom and Seex, 2011 | 26 | Self-assessment of sore throat, dysphagia, and dysphonia quantified with Likert scale | at 24 h: 46%; at 1 wk: 32% | x | Incidence: 5%; prevalence: x | x | x | x | x |
| Rihn et al, 2011 | 38 | Bazaz Dysphagia Score derived from answers to questionnaire and numeric rating scale | x | 71.0% | Incidence: x; prevalence: 26.0% | Incidence: x; prevalence: 8.0% | x | x | x |
| Fehlings et al, 2012 | 302 | Included only clinically apparent and significant forms | x | x | Incidence at < 30 d: 3%; prevalence: x | x | x | x | x |
| Kalb et al, 2012 | 249 | DDI (score of ≥ 30) | x | x | Incidence: 88.4%; prevalence: x | Incidence: x; prevalence: 29.6% | Incidence: 10.8%; prevalence: 7.4% | x | x |
Abbreviations: CSOQ, Cervical Spine Outcomes Questionnaire; DDI, Dysphagia Disability Index; N/A, not applicable; VAS, Visual Analog Scale.
Fig. 4Dysphagia following extrusion of bone graft. The patient underwent revision surgery and an anteroposterior fusion, with resolution of dysphagia symptoms several months after the second surgery.
Fig. 5Dysphagia following collapse of long-segment construct.
The factors most commonly reported as associated with an increased risk of oropharyngeal dysphagia after ACSS
| Age (older), |
| ACDF versus disk replacement/arthroplasty |
| Blood loss > 300 mL |
| Gender (female) |
| Use of plating |
| Operative levels (higher versus lower), |
| Number of levels operated (more) |
| Increased operative time, |
| Excessive or prolonged esophageal retraction pressure |
| Revision surgery |
| Smoking |
| Prevertebral soft tissue swelling, |
| Use of rh-BMP-2 |
| Soft tissue injury |
| Longer duration of current pain since first pain episode |
| Higher average intraluminal pressure throughout surgery and lower average mucosal perfusion |
| Scar tissue formation on a less smooth plate surface |
| Highest level of plate at C3 versus C4 and below |
Abbreviations: ACDF, anterior cervical discectomy and fusion; ACSS, anterior cervical spine surgery; rhBMP-2, recombinant human bone morphogenetic protein-2.
Intraoperative and postoperative techniques that may decrease the incidence and/or severity of oropharyngeal dysphagia after ACSS
| Use preoperative tracheal/esophageal traction exercise |
| Improve surgical techniques or make changes in perioperative management |
| Place retractor blades cautiously under the longus colli muscles |
| Release the endotracheal tube cuff and reinflate it after retractor placement to minimize pressure-related damage to the RLN |
| Decrease endotracheal tube cuff pressure to 20 mm Hg to improve patient comfort following ACSS |
| Limit operative time to < 175 min |
| Use smaller and smoother plates |
| Utilize a team approach during surgery: head and neck surgeon providing the exposure and neurosurgeon performing the procedures |
| Ensure knowledge of normal and aberrant courses of the SLN and RLN |
| Use low-dose oral steroids (methylprednisolone) perioperatively in selected patients to minimize neck/airway swelling and dysphagia in the acute period |
| Use a retropharyngeal local steroid (triamcinolone 40 mg) to control local inflammatory response thus reduce PSTS and airway swelling |
| Involve speech pathologists and otolaryngologists in the postsurgery evaluation, especially in cases of high risk |
| Introduce laryngeal diagnostic techniques and voice management early |
Abbreviations: ACSS, anterior cervical spine surgery; PSTS, prevertebral soft tissue swelling; RLN, recurrent laryngeal nerve; SLN, superior laryngeal nerve.